Cytosorbents Corp Stock OTC Bulletin Board
Equities
CTSO
US23283X1072
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 41.33M | Sales 2025 * | 46.93M | Capitalization | 45.16M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -9M | EV / Sales 2024 * | 1.09 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.96 x |
P/E ratio 2024 * |
-2.31
x | P/E ratio 2025 * |
-4.75
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
1st Jan change | Capi. | |
---|---|---|
+13.00% | 227B | |
+13.03% | 192B | |
+16.58% | 136B | |
+28.75% | 108B | |
+1.29% | 64.07B | |
+17.62% | 52.1B | |
+6.74% | 51.87B | |
+10.05% | 44.33B | |
+3.98% | 36.75B |